Anderson KM - Search Results

1

BMP-2 gene expression and effects on human vascular smooth muscle cells.

Willette RN, Gu JL, Lysko PG, Anderson KM, Minehart H, Yue T. Willette RN, et al. Among authors: anderson km. J Vasc Res. 1999 Mar-Apr;36(2):120-5. doi: 10.1159/000025634. J Vasc Res. 1999. PMID: 10213907

2

The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.

Anderson KM, Eckhart AD, Willette RN, Koch WJ. Anderson KM, et al. Hypertension. 1999 Jan;33(1 Pt 2):402-7. doi: 10.1161/01.hyp.33.1.402. Hypertension. 1999. PMID: 9931137

3

Molecular characterization of a human scavenger receptor, human MARCO.

Elshourbagy NA, Li X, Terrett J, Vanhorn S, Gross MS, Adamou JE, Anderson KM, Webb CL, Lysko PG. Elshourbagy NA, et al. Among authors: anderson km. Eur J Biochem. 2000 Feb;267(3):919-26. doi: 10.1046/j.1432-1327.2000.01077.x. Eur J Biochem. 2000. PMID: 10651831 Free article.

4

Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction.

Willette RN, Anderson KM, Nelson AH, Olzinski AR, Woods T, Coatney RW, Aiyar N, Ohlstein EH, Barone FC. Willette RN, et al. Among authors: anderson km. J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013. J Cardiovasc Pharmacol. 2001. PMID: 11588531

5

Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells.

Anderson KM, Roshak A, Winkler JD, McCord M, Marshall LA. Anderson KM, et al. J Biol Chem. 1997 Nov 28;272(48):30504-11. doi: 10.1074/jbc.272.48.30504. J Biol Chem. 1997. PMID: 9374544 Free article.

6

cDNA sequence and characterization of the gene that encodes human myotrophin/V-1 protein, a mediator of cardiac hypertrophy.

Anderson KM, Berrebi-Bertrand I, Kirkpatrick RB, McQueney MS, Underwood DC, Rouanet S, Chabot-Fletcher M. Anderson KM, et al. J Mol Cell Cardiol. 1999 Apr;31(4):705-19. doi: 10.1006/jmcc.1998.0903. J Mol Cell Cardiol. 1999. PMID: 10329199

7

Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal disease.

Ali SM, Laping NJ, Fredrickson TA, Contino LC, Olson Ba, Anderson K, Brooks DP. Ali SM, et al. Pharmacology. 1998 Jul;57(1):20-7. doi: 10.1159/000028222. Pharmacology. 1998. PMID: 9670209

8

Anti-human RP105 sera induces lymphocyte proliferation.

Roshak AK, Anderson KM, Holmes SD, Jonak Z, Bolognese B, Terrett J, Marshall LA. Roshak AK, et al. Among authors: anderson km. J Leukoc Biol. 1999 Jan;65(1):43-9. doi: 10.1002/jlb.65.1.43. J Leukoc Biol. 1999. PMID: 9886245

9

Rapid generation of homologous internal standards and evaluation of data for quantitation of messenger RNA by competitive polymerase chain reaction.

Anderson KM, Cheung PH, Kelly MD. Anderson KM, et al. J Pharmacol Toxicol Methods. 1997 Nov;38(3):133-40. doi: 10.1016/s1056-8719(97)00078-6. J Pharmacol Toxicol Methods. 1997. PMID: 9523766

10

Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis.

Capper EA, Roshak AK, Bolognese BJ, Podolin PL, Smith T, Dewitt DL, Anderson KM, Marshall LA. Capper EA, et al. Among authors: anderson km. J Pharmacol Exp Ther. 2000 Dec;295(3):1061-9. J Pharmacol Exp Ther. 2000. PMID: 11082441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page